Olema Pharmaceuticals, Inc. (OLMA)
Nasdaq: OLMA · CIK 0001750284 · United States
Every official Olema Pharmaceuticals, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open OLMA filings
Olema Pharmaceuticals, Inc. documents
- Olema Pharmaceuticals, Inc. 10-K 2026OLMA 10-K 2026: annual report for fiscal 2026
- Olema Pharmaceuticals, Inc. 10-K 2025OLMA 10-K 2025: annual report for fiscal 2025
- Olema Pharmaceuticals, Inc. 10-K 2024OLMA 10-K 2024: annual report for fiscal 2024
- Olema Pharmaceuticals, Inc. 10-K 2023OLMA 10-K 2023: annual report for fiscal 2023
- Olema Pharmaceuticals, Inc. 10-K 2022OLMA 10-K 2022: annual report for fiscal 2022
- Olema Pharmaceuticals, Inc. 10-Q 2026OLMA 10-Q 2026: quarterly report for fiscal 2026
- Olema Pharmaceuticals, Inc. 10-Q 2025OLMA 10-Q 2025: quarterly report for fiscal 2025
- Olema Pharmaceuticals, Inc. 10-Q 2024OLMA 10-Q 2024: quarterly report for fiscal 2024
- Olema Pharmaceuticals, Inc. 10-Q 2023OLMA 10-Q 2023: quarterly report for fiscal 2023
- Olema Pharmaceuticals, Inc. 10-Q 2022OLMA 10-Q 2022: quarterly report for fiscal 2022
- Olema Pharmaceuticals, Inc. 8-K 2026OLMA 8-K 2026: current report for fiscal 2026
- Olema Pharmaceuticals, Inc. 8-K 2025OLMA 8-K 2025: current report for fiscal 2025
- Olema Pharmaceuticals, Inc. 8-K 2024OLMA 8-K 2024: current report for fiscal 2024
- Olema Pharmaceuticals, Inc. 8-K 2023OLMA 8-K 2023: current report for fiscal 2023
- Olema Pharmaceuticals, Inc. 8-K 2022OLMA 8-K 2022: current report for fiscal 2022
- Olema Pharmaceuticals, Inc. DEF 14A 2026OLMA DEF 14A 2026: proxy statement for fiscal 2026
- Olema Pharmaceuticals, Inc. DEF 14A 2025OLMA DEF 14A 2025: proxy statement for fiscal 2025
- Olema Pharmaceuticals, Inc. DEF 14A 2024OLMA DEF 14A 2024: proxy statement for fiscal 2024
- Olema Pharmaceuticals, Inc. DEF 14A 2023OLMA DEF 14A 2023: proxy statement for fiscal 2023
- Olema Pharmaceuticals, Inc. DEF 14A 2022OLMA DEF 14A 2022: proxy statement for fiscal 2022
- Olema Pharmaceuticals, Inc. Form 4 2026OLMA Form 4 2026: insider trading filing for fiscal 2026
- Olema Pharmaceuticals, Inc. Form 4 2025OLMA Form 4 2025: insider trading filing for fiscal 2025
- Olema Pharmaceuticals, Inc. Form 4 2024OLMA Form 4 2024: insider trading filing for fiscal 2024
- Olema Pharmaceuticals, Inc. Form 4 2023OLMA Form 4 2023: insider trading filing for fiscal 2023
- Olema Pharmaceuticals, Inc. Form 4 2022OLMA Form 4 2022: insider trading filing for fiscal 2022
- Olema Pharmaceuticals, Inc. S-1 2026OLMA S-1 2026: registration statement for fiscal 2026
- Olema Pharmaceuticals, Inc. S-1 2025OLMA S-1 2025: registration statement for fiscal 2025
- Olema Pharmaceuticals, Inc. S-1 2024OLMA S-1 2024: registration statement for fiscal 2024
- Olema Pharmaceuticals, Inc. S-1 2023OLMA S-1 2023: registration statement for fiscal 2023
- Olema Pharmaceuticals, Inc. S-1 2022OLMA S-1 2022: registration statement for fiscal 2022
- Olema Pharmaceuticals, Inc. 13F 2026OLMA 13F 2026: institutional holdings for fiscal 2026
- Olema Pharmaceuticals, Inc. 13F 2025OLMA 13F 2025: institutional holdings for fiscal 2025
- Olema Pharmaceuticals, Inc. 13F 2024OLMA 13F 2024: institutional holdings for fiscal 2024
- Olema Pharmaceuticals, Inc. 13F 2023OLMA 13F 2023: institutional holdings for fiscal 2023
- Olema Pharmaceuticals, Inc. 13F 2022OLMA 13F 2022: institutional holdings for fiscal 2022
More companies